Pierre Perrin-Monlouis Dernière mise à jour: 20 octobre 2021
Eurofins today announces that it has agreed an outsourcing deal (with effect 1 September 2008) with the Finnish-based food and feed producer Raisio Group, best known internationally for its Benecol-branded products. Under the terms of the deal Eurofins will take on Raisio’s food and grain testing laboratories, its equipment and employees and in return will carry out testing services needed by Raisio over the next five years. As with other recent outsourcing transactions Eurofins plans that besides providing market-leading, accredited testing services and expertise under this contract, opportunities exist to derive third-party testing work in the fast-growing Finnish domestic and export markets in foodstuffs and non-alcoholic beverages.
The Raisio Group laboratories are based in the town of Raisio itself, centred in a major food-producing region in the south of Finland. Eurofins plans to transfer much of the existing food testing business that is presently done at Eurofins Finland’s Tampere laboratory and divert samples that are currently being sent to Sweden and other parts of Europe. The Group established a base in the country at the Tampere lab only recently, following the acquisition of the Lantmännen Analycen Group in October 2007 and it now has further possibilities to establish fully its laboratory network in the country.
As usual on its outsourcing deals, Eurofins expects the transaction to benefit both parties:
From an operating point of view, by outsourcing a non-core activity Raisio will obtain its testing results in a much faster Turn-Around Time (TAT), have access to a broader range of tests and be able to draw on the expertise of internationally recognised scientists available across the Eurofins Group, all at competitive prices. In general, companies that do this are able to improve their return on capital and transfer the risk of fixed costs into variable costs.
At the same time the Eurofins Group sees an opportunity to create significant long-term value in line with its standard financial and operational objectives: high levels of return on capital through efficient laboratory management and higher sales, increasing economic profit and market leadership in fast-growing markets.
This is the latest in a general trend of outsourcing deals that Eurofins has seen in each of its main markets (food, pharma and environment) around the world since 2001. The trend started with the Novartis Medinet lab in Breda and the Glon Sanders CRCB feed testing laboratory in France and has been progressing steadily throughout the last few years, to such an extent that previously sensitive testing facilities such as Southern Water in the UK and the National Water Reference Laboratory of Denmark have proved to be highly successful projects for the outsourcing body as well as for Eurofins.
For further information please visit www.eurofins.com or contact: Investor Relations Phone: +32-2-769 7383 E-mail: [email protected]
Notes for the editor:
Eurofins – a global leader in bio-analysis Eurofins Scientific is a life sciences company operating internationally to provide a comprehensive range of analytical testing services to clients from a wide range of industries including the pharmaceutical, food and environmental sectors. With about 7,000 staff in more than 150 laboratories across 28 countries, Eurofins offers a portfolio of over 25,000 reliable analytical methods for evaluating the authenticity, origin, safety, identity, composition and purity of biological substances and products. The Group is committed to provide its customers with high quality services, accurate results in time and, if requested, expert advice by our highly qualified staff.
The Eurofins Group is one of the global market leaders in this field of applied life sciences. It intends to pursue its dynamic growth strategy and expand both its technology portfolio and its geographic reach. Through R&D, in-licensing and acquisitions, the Group draws on the latest developments in the field of biotechnology to offer its clients unique analytical solutions and the most comprehensive range of testing methods. As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the NYSE Euronext Paris (ISIN FR0000038259) and Frankfurt (WKN 910251) Stock Exchanges (Reuters EUFI.LN, Bloomberg ERF FP, ESF, EUFI.DE).
Raisio Group Raisio is a forerunner in the food and feed industries and a specialist in plant-based nutrition. A raw material base consisting of cultivated products offers Raisio good opportunities to develop as a company with ecologically sustainable operations. Raisio’s main products are foods and functional food ingredients, as well as feeds and malts. The company plays an important role in ensuring a safe quality chain from field to table.
Raisio has nearly 1,100 employees in nine countries. The company has production in seven locations in three countries. The business is based on meeting customers’ and consumers’ needs with natural, safe and healthy products. Innovative research and development, modern production facilities, high-quality and traceable raw materials and efficient production processes ensure profitable continuity of operations.
Financial, environmental and social responsibility form an important part of Raisio’s operating philosophy. Raisio promotes responsible operations at all of its sites in co-operation with goods and service providers and other stakeholders. It regularly monitors and measures its responsibility. Raisio’s shares are listed on the OMX Nordic Exchange Helsinki. The Group’s headquarters are located in Raisio, Finland. Raisio consists of three divisions: Food (turnover EUR 197.1 million in 2007), Feed and Malt (turnover EUR 206.7 million in 2007) and Ingredients (turnover EUR 44.9 million in 2007).
Important disclaimer: This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the data available to the Company as of the date of publication, but no guarantee can be made as to their validity.
